Background. Human bocavirus (HBoV) is a newly described parvovirus. HBoV1 has been associated with respiratory infections, including acute otitis media (AOM), but the knowledge on the significance of HBoV1 in upper respiratory tract infections (URI) and AOM in relation to other respiratory viruses is limited. The objective of this study was to compare the rate of detection of HBoV1 to that of other respiratory viruses in specimens from children with URI, with and without AOM complication. Methods. Nasopharyngeal secretions (NPS) were collected during URI from healthy children (6-35 months) followed prospectively for 1 year; specimens have been previously analyzed for broad spectrum of respiratory viruses. Archived NPS were analyzed for HBoV1 using a high-throughput, quantitative polymerase chain reaction method. Results. Seven hundred and seven NPS samples collected during URI episodes from 201 children were studied for HBoV1. A total of 94 (47%) children tested positive for HBoV1 DNA during 172 (24%) URI episodes; HBoV1 was present as the only virus in 44 (6%) URI episodes. Overall, 37% of URI episodes were complicated by AOM. Of URI associated with single virus (n = 303), the rate of AOM complicating URI associated with HBoV1 only was 52% (23 of 44); this was a higher AOM rate, compared to that of other respiratory viruses. Conclusions. Among URI associated with single respiratory virus, HBoV1-URI was commonly associated with AOM complication. The important role of HBoV1 on AOM pathogenesis needs to be studied further.
the same subjects [15] . The cause-and-effect relationship of HBoV detection in respiratory specimens and the presence of HBoV in children over time still need to be studied further. We investigated the presence of HBoV1-DNA in NPS from young children with URI to determine the role of HBoV1 in URI and AOM, and we compared the rate of AOM complicating HBoV1-URI to that of URI associated with other viruses.
STUDY DESIGN Study Design and Subjects
Specimens tested for HBoV1 were archived specimens from a prospective, longitudinal study performed between January 2003 and March 2007 at the University of Texas Medical Branch (Galveston, TX) [10] . Constitutionally healthy children were enrolled at the ages of 6-35 months and followed for 1 year for occurrences of URI and AOM. The parents informed the study personnel when the child developed URI symptoms. Children were seen by a study physician and followed after URI onset for the occurrence of AOM. At each visit, otoscopic and physical examinations and tympanometry were performed. Acute otitis media was considered to have complicated URI if it occurred within 28 days of URI onset. Acute otitis media was defined as acute onset of symptoms, signs of tympanic membrane inflammation (erythema, opacification, or bugling), and the presence of fluid in the middle ear. The study was approved by the Institutional Review Board of University of Texas Medical Branch, and informed consent was obtained from the guardians of all study children.
Virologic Studies
Respiratory specimens for viral studies were collected at the initial URI visit and when AOM was diagnosed. Nasal swabs were collected for viral culture and NPS for other viral studies. The NPS sample was collected by vacuum suction catheter with mucus trap, which were rinsed with 1 mL phosphate-buffered saline. The total secretion volume was recorded to provide the dilution factor of the original sample.
Respiratory specimens were collected during 864 URI episodes in the original study [10] . The NPS samples collected during RSV season were also analyzed for RSV antigen detection by enzyme immunoassay (EIA). Culture and RSV-EIA-negative samples were tested by real-time polymerase chain reaction (PCR) for adenovirus, enterovirus, rhinovirus, and coronavirus (OC43, 229E, and NL63) and by microarray PCR for RSV A and B, parainfluenza viruses 1-3, and influenza viruses A and B, performed at the Medical College of Wisconsin (Milwaukee, WI). The HBoV1 and human metapneumovirus (hMPV) were not targeted in the assay performed and reported in the original study. Specific to this report, 707 frozen archived NPS specimens were available for testing by quantitative PCR (qPCR) for hMPV, HBoV, and RSV; these represent 81% of the URI samples collected for viral studies. All of the results from previous and new virological analysis of these 707 samples were included in this study.
Nucleic acid extraction and qPCR were performed in a "clean room" facility within the Galveston National Laboratory (University of Texas Medical Branch) using MagMAX Total Nucleic Acid isolation kits (Ambion/ Applied Biosystems, Austin, TX) and a Biosprint 96 (QIAGEN, Valencia, CA). A customized script directed the extraction protocol to optimally recover RNA and DNA from each sample. After extraction, the elution volume (200 µL) was diluted 1:1 with nuclease-free 0.1 mM EDTA (Ambion/Applied Biosystems, Austin, TX) and distributed to daughter plates for subsequent analyses.
DNA from each sample was evaluated using a duplex qPCR assay with primers that amplified targets within the HBoV1 NS-1 region [16] and human glyceraldehyde 3-phosphate dehydrogenase (hGAPDH) [17] . Glyceraldehyde 3-phosphate dehydrogenase was used as an indicator of sample integrity and extracted nucleic acid quality. TaqMan probes were used to track the specific amplification in the duplex. Quantitative PCR was completed in a C1000 thermocycler equipped with a CFX reaction module (Bio-Rad) using the following parameters: Cycle 1: 95°C (3 minutes); Cycle 2, Step 1: 95°C (15 seconds),
Step 2: 60°C (45 seconds), repeated 50 times. Fluorescent signal data were collected at the end of each annealing and extension step. Viral genomic titers were extrapolated from standard curves of plasmids harbouring the PCR targets generated in parallel for each run. A parallel qPCR reaction for GAPDH [17] was completed on every clinical sample to evaluate RNA and cDNA quality. Detection of hGAPDH at less than 500 copies/reaction from the NPS sample suggested inadequacy of the specimen and led to the exclusion of the sample from further analysis. Viral load was calculated as HBoV1-DNA copies/mL of the original specimen based on the original dilution of the specimens and subsequent assay dilutions. Due to unknown dilution of 58 NPS samples, viral load analysis was available in NPSs from 649 URI episodes.
In addition to HBoV1 qPCR, duplex hMPV-RSV-qPCR was also performed; hMPV data have been reported previously [18] . Virology results reported here combined data from qPCR and data from the original study [10] . For RSV, previous PCR data were performed only in culturenegative and EIA-negative samples by microarray, which is less sensitive than real-time PCR [19] . As a result, new detection of RSV was made by qPCR in 71 URI episodes, including 38 episodes with RSV as the single virus.
Statistics
Comparisons were made using Fisher's exact test for 2 × 2 tables and t tests. For viral load, log transformations were applied to make standard deviations comparable. To compare number of URI episodes, Poisson regression with a categorical predictor was used and assessed for goodnessof-fit. All calculations were carried out in R, a software environment for statistical computing and graphics (http://cran. r-project.org).
RESULTS
The HBoV1 testing was performed in 707 NPS samples collected during URI from 201 children. Demographic characteristics and risk factor data are presented in Table 1 , which also compares data from children who had 1 or more URI episode with HBoV1 detection with those without. Children with HBoV1 infection had significantly more frequent URI episodes, compared with children without HBoV1 infection; they also have more URI episodes associated with multiple viruses. Of 94 children with HBoV1 infection, HBoV1 was detected more than once in 42 (45%) children during the year. In 23 children, HBoV1 was detected twice: in 10 children, 3 times; in 5 children, 4 times; in 2 children, 5 times; in 1 child, 6 times; and 1 child had 8 HBoV-positive URI episodes during the study period. The pattern of multiple HBoV1 detections varied in the 42 children: multiple detection in consecutive samples, which suggests persistence (n = 23); 2 or more HBoV1 detections with at least 1 negative detection in between, which suggests either reinfection or periodic shedding (n = 19). The interval between HBoV1-positive URI episodes ranged from 8 to 301 days (with or without HBoV1-negative episodes in between).
Respiratory viruses were detected in 542 (77%) NPS samples; of these, 303 (43%) contained a single virus. HBoV1 was detected in 172 (24%) URI episodes ( Table 2 ). In 44 URI episodes (6% of all episodes), HBoV1 was the only respiratory virus detected; in 128, another virus was also detected, most often adenovirus, enterovirus, and rhinovirus (46, 40, and 36 episodes, respectively). The HBoV1 was detected year-round, with 63% between October and March. There was no significant difference in signs and symptoms at the time of sick visit between the children with HBoV1 as a single virus and the children without HBoV1 (data not shown).
Overall, 37% of all URI episodes, 39% of virus-positive URI episodes (single or multiple viruses), and 45% of HBoV1-positive episodes (single or multiple viruses) were complicated by AOM. Of URI associated with the presence of a single virus, the rate of AOM complicating URI was 52% in HBoV1-positive episodes. The rates of AOM complicating URI for other viruses are presented in Table 2 . Although presence of HBoV1 alone in the child with acute onset of URI, without other viruses detected, suggests the association between HBoV1 and acute URI 
DISCUSSION
In this longitudinal study to determine URI and AOM occurrences in young children, we frequently detected HBoV1 alone or in combination with other viruses during URI. The unique feature of our study is the comparison of the rate of AOM complicating URI associated with single respiratory virus. We found that a high proportion of HBoV1-associated URI episodes were complicated by AOM. Our findings suggest that HBoV1 may play an important role in AOM pathogenesis, similar to other viruses such as RSV, adenoviruses, and coronaviruses [10, 20] .
The HBoV1 is now recognized as a respiratory virus [5] ; it has been detected in the MEF of children with AOM [12] and active HBoV1 infection documented by serology significantly associate with AOM development [14] . However, it is known that HBoV-DNA can be detected in asymptomatic children [15] due to prolonged presence of the viral nucleic acids. Therefore, detection of HBoV1-DNA alone in the NPS might not be sufficient to document active HBoV1 infection. Unfortunately, we were unable to confirm active HBoV1 infection in our study by serology. Due to the longitudinal nature of the study and nonsevere nature of viral URI and AOM, we were not able to include blood drawing for acute and convalescent serology in our design. Nevertheless, indirect evidence exists to support the role of active HBoV1 infection in our cases with URI associated with HBoV1 alone. First, we used extensive viral diagnostic methods to detect a variety of common respiratory viruses during symptomatic URI, although we did not detect less common, newly described viruses such as polyomaviruses and parechoviruses. Negative findings for other viruses but positive finding for HBoV1 only suggested the association between HBoV1 (a recognized respiratory virus) and acute symptoms. Second, viral load in the cases of HBoV1 alone was relatively high (mean viral load, 1. ). Lastly, in our recently published study using NPS samples from the same cohort [21] , concentrations of lactate dehydrogenase, a marker for cellular injury during inflammation, are associated with the rate of AOM complication after URI and with the presence of adenovirus, rhinovirus, and HBoV1. These findings together support the association between the presence of HBoV1 and its clinical significance during URI episodes for which no other virus was detected. Total number of viruses = 867.
The incidence of HBoV1 detection in our patients with URI (24%) is among the highest published; overall, the incidence of HBoV has ranged from 5% to 33% in children with respiratory infection [2-4, 15, 22-23] . The higher incidence of HBoV detection in longitudinal studies, compared with that in cross-sectional studies, is likely from prolonged presence of the virus in the respiratory tract. The same reason may also explain high frequencies of concurrent detection of HBoV with other viruses, which has been reported to occur up to 72% [13, 15, 22, [24] [25] . In our study, 45% of children with HBoV1 in the NPS had the virus detected more than once. Prolonged shedding of HBoV1 in nasal secretions has been described up to 11 weeks in children attending day care [15] and up to 3 months in otitis-prone children [26] . Extended viral shedding has also been observed with other DNA-viruses; in the same study population, we studied genetic sequences of adenoviruses and found that repeated presence could be from the same viral serotype and strain detected continuously or intermittently, or different serotype or strain detected sequentially [27] . Further studies of the viral genome in children with sequential HBoV1 are required, to differentiate between prolonged presence of the viral and reinfection with different HBoV isolates. These types of studies will help elucidate the natural history and foster the understanding of the pathogenicity of HBoV1 infection.
In conclusion, HBoV1 was a common virus detected alone or in combination with other respiratory viruses during URI. Among cases of URI associated with presence of single virus, HBoV1-URI was associated with a high rate of AOM complication.
